InsiderSource
SRTA

Strata Critical Medical, Inc.

SEC CIK 1779128
$5.89 +33.9% · 90 days
90-day buys
$0
0 open-market
90-day sells
$802.6K
7 open-market
Net insider flow
−$802.6K
Net selling
Filings shown
29
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at SRTA have sold a net $802.6K of stock (0 open-market buys vs 7 sells).

Largest recent trade: Cohen Amir sold $239.8K of SRTA, trimming their stake 21%.

Most active filer: Cohen Amir, with 9 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for SRTA, newest first
View on SEC EDGAR ↗
SRTA
Strata Critical Medical, Inc.
Sell Cohen Amir · Chief Accounting Officer · Open-market sale · filed 6d ago ΔOwn −3.1%

Cohen Amir sold $27.3K of SRTA, trimming their stake 3%.

−$27.3K
4,655 sh @ $6
SRTA
Strata Critical Medical, Inc.
Sell Tomkiel Melissa M. · Director, Co-CEO and General Counsel · Open-market sale · filed 6d ago ΔOwn −1.5%

Tomkiel Melissa M. sold $174.5K of SRTA, trimming their stake 2%.

−$174.5K
29,730 sh @ $6
SRTA
Strata Critical Medical, Inc.
Sell Cohen Amir · Chief Accounting Officer · Open-market sale · filed 3w ago ΔOwn −21%

Cohen Amir sold $239.8K of SRTA, trimming their stake 21%.

−$239.8K
40,575 sh @ $6
Advertisement
SRTA
Strata Critical Medical, Inc.
Sell Cohen Amir · Chief Accounting Officer · Open-market sale · filed 3w ago ΔOwn −5.1%

Cohen Amir sold $59.6K of SRTA, trimming their stake 5%.

−$59.6K
10,300 sh @ $6
SRTA
Strata Critical Medical, Inc.
Sell Cohen Amir · Chief Accounting Officer · Open-market sale · filed May 13, 2026 ΔOwn −6.6%

Cohen Amir sold $82.8K of SRTA, trimming their stake 7%.

−$82.8K
14,306 sh @ $6
SRTA
Strata Critical Medical, Inc.
Buy Heyburn William A. · Director, Co-CEO and CFO · Open-market purchase · filed Dec 10, 2025 ΔOwn +1.2%

Heyburn William A., SRTA's CEO, spent $76K of their own money on 17,000 shares at $4, growing their stake 1%.

+$76K
17,000 sh @ $4
SRTA
Strata Critical Medical, Inc.
Buy LAUCK ANDREW · Director · Open-market purchase · filed Dec 5, 2025 ΔOwn +3.8%

Lauck Andrew, SRTA's Director, spent $21.8K of their own money on 5,000 shares at $4, growing their stake 4%.

+$21.8K
5,000 sh @ $4
Advertisement

About SRTA insider activity

This page tracks every recent Form 4 filed for Strata Critical Medical, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is SRTA insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Strata Critical Medical, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.